On Wednesday, April 1, U.S. stock markets opened strongly following optimism over a potential resolution to the Iran conflict and a better-than-expected ADP employment report. Jim Cramer identifies ten key stocks to monitor, highlighting both opportunities and risks.
Market Context
Wall Street saw another strong open after yesterday's rally driven by hopes for an end to the Iran war. The March ADP report exceeded expectations, signaling a positive jobs market ahead of Friday's nonfarm payrolls data.
Top 10 Things to Watch
- Market Open: The strong opening reflected yesterday's scorching rally on Iran resolution hopes, with the ADP report providing a preview of potential market moves if the conflict ends.
- Nike (NKE): Despite a quarterly beat on revenue and earnings, Nike issued weak guidance, faced inventory issues, and saw North America growth slow. Downgraded by Goldman Sachs, JPMorgan, and Bank of America.
- RH (RH): The luxury home-furnishings maker missed all key metrics in its fiscal fourth quarter and provided light current-quarter guidance. Tariffs and a difficult housing market pressured shares down 18%, though full-year cash flow guidance improved.
- Arm (ARM): Wells Fargo raised its price target to $175 from $165, citing Arm's push into the data center CPU market with in-house silicon. Analysts reiterated a buy rating, noting competition with Intel and AMD.
- Constellation Brands (STZ): Evercore added the Modelo brewer to its tactical buy list. Incoming CEO Nick Fink is expected to turn around the company as beer sales strengthen, with Citi having upgraded it last month.
- Boeing (BA): Wells Fargo initiated coverage with a buy rating and $250 price target, implying over 25% upside. Analysts favor Boeing's free cash flow recovery as production normalizes under CEO Kelly Ortberg.
- Rockwell Automation (ROK) and Eaton (ETN): Wells Fargo lowered price targets for both industrial stocks due to caution about new orders amid Iran-U.S. war uncertainty. Rockwell's target cut to $360 from $410; Eaton's to $350 from $370.
- Atlassian (TEAM): KeyBanc saw encouraging demand but slashed its price target to $130 from $170, reflecting SaaS stock pressures from AI disruption, where markets are less willing to pay premium valuations.
- Edwards Lifesciences (EW): Upgraded to buy by Wolfe Research, as competitor Medtronic's recent data issues position Edwards to gain share in the TAVR heart valve replacement market.
- Sempra (SRE): Added to Wells Fargo's tactical ideas list. Cramer favors this growth utility for its Texas and California exposure and its plan to sell a majority stake in its infrastructure business to focus on core operations.
Note: Cramer's analysis is based on his CNBC Investing Club and Charitable Trust portfolio, with trade alerts subject to specific timing rules.
